Cell and Gene Manufacturing and Logistics
-
Addressing Challenges In Serialization For Complex Therapeutics
5/7/2024
The magnitude of serialization, especially for firms with extensive portfolios and intricate supply chains, poses serious challenges. This discussion offers solutions.
-
Process Liquids Preparation Services For Biopharmaceutical Manufacturers
5/7/2024
Explore process liquids preparation services and custom solutions for biopharmaceutical manufacturers.
-
21 CFR Part 11 Compliance Checklist For A Universal Pump
5/7/2024
This checklist provides a detailed look at the requirements of 21 CFR Part 11 and highlights how the Sterisart® Universal | Gen 4 - Advanced supports your efforts to meet these regulatory demands.
-
Sterility Testing For A Connected Era
5/7/2024
This pump combines state-of-the-art hardware with sophisticated, user-friendly software to offer compliant, paperless documentation and reporting.
-
Unlocking the Future of Allogeneic Cell Therapy for Oncology | Audience Q&A
5/6/2024
Expert panelists in this Cell & Gene Therapy Live presentation provided detailed responses to questions about the potential risks of CAR-T therapy, screening criteria for donor material, comparability, and more.
-
Autoimmune Disease Research’s Impact on the Development of Cell Therapies for Oncology
5/6/2024
Recently, many cell therapy companies have been pivoting to autoimmune diseases. Expert panelists discuss whether they think there are any learnings or potential headwinds these pivots could provide to cell therapies for oncology.
-
Defining the CMC / Clinical Relationship for Allogeneic Cell Therapies
5/6/2024
During this segment, Nguyen and Wagner define why the relationship between CMC and Clinical is so critical, and they also explain what a mutually beneficial partnership between CMC and Clinical looks like.
-
Improvements in Scaling and Sequencing for Allogeneic Cell Therapies for Oncology
5/6/2024
During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.
-
Best Practices for Effective Donor Management
5/6/2024
Starting with high quality donor material is critical for allogeneic cell therapy drug manufacturing, and this requires laying the groundwork for a high-touch, end-to-end donor pool management strategy.
-
Major Trends Impacting Allogeneic Cell Therapies for Oncology
5/6/2024
We kicked off this Cell & Gene Live, Unlocking the Future of Allogeneic Cell Therapy for Oncology by discussing the major trends impacting allogeneic cell therapies for oncology.